Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
J Patient Rep Outcomes. 2023 Mar 21;7(1):31. doi: 10.1186/s41687-023-00572-0.
The novel Coronavirus (COVID-19) has continued to present a significant burden to global public health efforts. The purpose of this study was to estimate the health-related quality of life, disability, and health status of individuals with self-reported long COVID at various lengths of recovery.
We conducted a cross-sectional online survey of individuals with self-reported long COVID. Participants were asked to complete the five-item EuroQOL EQ-5D-5L and EQ visual analog scale, the 12-item World Health Organization Disability Assessment Schedule (WHODAS) 2.0 and the 10-item Patient Reported Outcome Measurement Information System (PROMIS) Global Health v1.2 short form. Descriptive and inferential statistics were used to characterize the responses and differences across groups.
Eighty-two participants from 13 countries completed the EQ-5D-5L, 73 completed the WHODAS 2.0 and 80 participants completed the PROMIS. The mean EQ-5D-5L utility score was 0.51. The mean WHODAS score was 49.0. In the previous 30 days, participants reported their symptoms affected them for a mean of 24 days, they were totally unable to carry out usual activities for 15 days, and they cut back or reduced activities for 26 days. The mean PROMIS physical health and mental health scores were 10.7 and 8.6, respectively, corresponding to below-average health. No significant differences were detected across time or according to severity of acute infection.
Long COVID presents a significant chronic health burden to adults in the US and abroad. This health burden may persist for many months post-acute infection.
新型冠状病毒(COVID-19)继续对全球公共卫生工作造成重大负担。本研究的目的是评估在不同康复时间长度下自我报告的长 COVID 个体的健康相关生活质量、残疾和健康状况。
我们对自我报告的长 COVID 个体进行了横断面在线调查。要求参与者完成五分量表欧洲五维健康量表(EQ-5D-5L)和 EQ 视觉模拟量表、12 项世界卫生组织残疾评估量表(WHODAS)2.0 和 10 项患者报告结局测量信息系统(PROMIS)全球健康 v1.2 简短形式。使用描述性和推断性统计来描述反应和组间差异。
来自 13 个国家的 82 名参与者完成了 EQ-5D-5L,73 名参与者完成了 WHODAS 2.0,80 名参与者完成了 PROMIS。EQ-5D-5L 效用评分的平均值为 0.51。WHODAS 评分的平均值为 49.0。在过去的 30 天内,参与者报告他们的症状平均影响了他们 24 天,他们完全无法进行日常活动 15 天,他们减少或减少活动 26 天。PROMIS 生理健康和心理健康的平均得分为 10.7 和 8.6,分别对应于低于平均水平的健康。在时间或根据急性感染的严重程度方面未发现显著差异。
长 COVID 给美国和国外的成年人带来了重大的慢性健康负担。这种健康负担可能会在急性感染后持续数月。